ZNTL
Zentalis Pharmaceuticals Inc
Price:  
1.43 
USD
Volume:  
545,613.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ZNTL WACC - Weighted Average Cost of Capital

The WACC of Zentalis Pharmaceuticals Inc (ZNTL) is 6.8%.

The Cost of Equity of Zentalis Pharmaceuticals Inc (ZNTL) is 8.55%.
The Cost of Debt of Zentalis Pharmaceuticals Inc (ZNTL) is 5.00%.

Range Selected
Cost of equity 7.30% - 9.80% 8.55%
Tax rate 0.20% - 0.20% 0.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.1% - 7.4% 6.8%
WACC

ZNTL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.74 0.89
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.30% 9.80%
Tax rate 0.20% 0.20%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.1% 7.4%
Selected WACC 6.8%